Related references
Note: Only part of the references are listed.
Article
Biochemical Research Methods
Shaolei Teng et al.
Summary: This study quantified the systemic effects of missense mutations on the SARS-CoV-2 spike protein, revealing that most mutations destabilize the protein while specific mutations can enhance stability. The research also identified crucial residues affecting the RBD-ACE2 interaction, providing potential target sites for drug and vaccine development against COVID-19.
BRIEFINGS IN BIOINFORMATICS
(2021)
Article
Multidisciplinary Sciences
Bryan A. Johnson et al.
Summary: The genetic mutation in SARS-CoV-2 resulted in better fitness in some cells but lower replication capacity in human respiratory cell lines. Despite reducing disease symptoms, the Delta PRRA mutant provided protection against rechallenge with the wildtype SARS-CoV-2.
Article
Microbiology
Gabriele Cerutti et al.
Summary: Structural analysis revealed that seven potent NTD-directed neutralizing antibodies target a common surface on NTD, forming a single supersite different from the recognition pattern of RBD-directed antibodies.
CELL HOST & MICROBE
(2021)
Article
Multidisciplinary Sciences
Erik Laurini et al.
Summary: The study found that certain mutations in the SARS-CoV-2 spike protein can significantly resist antibody neutralization, while others can help the viral protein evade antibody action. Overall, there was a 90% agreement between the global in silico results and relevant experimental data, providing a molecular rationale and a tool for identifying circulating variants and developing more resilient vaccines and monoclonal antibodies.
SCIENTIFIC REPORTS
(2021)
Article
Biochemistry & Molecular Biology
Hin Hark Gan et al.
Summary: The study reveals that new variants of the SARS-CoV-2 Spike protein show enhanced binding affinity to the human ACE2 receptor, potentially increasing transmissibility. Structural analysis predicts variant combinations with both enhanced affinity and antibody resistance, highlighting the complexity of viral evolution and potential impact on intervention strategies.
JOURNAL OF MOLECULAR BIOLOGY
(2021)
Article
Multidisciplinary Sciences
Mohamed Raef Smaoui et al.
Summary: The interaction between the receptor-binding domain (RBD) of the SARS-CoV-2 spike glycoprotein and the ACE2 enzyme is crucial for the virus to enter cells, and current therapeutic efforts aim to affect this interaction. Analyzing spike protein mutations and toxicity potential provides insights for future vaccine development. Through computational exploration, potential mutations that can stabilize the spike protein and increase infectivity have been identified.
SCIENTIFIC REPORTS
(2021)
Article
Multidisciplinary Sciences
Amarendra Pegu et al.
Summary: The study assessed the impact of SARS-CoV-2 variants on antibody responses induced by the mRNA vaccine over 7 months, showing that most individuals maintained binding and functional antibodies against variants, with B.1.351 having the lowest antibody recognition.
Article
Virology
Jyoti Verma et al.
Summary: Research shows that the variants of the novel coronavirus increase its binding affinity with human cells, thereby enhancing the virus's infectivity and pathogenicity. Understanding the impact of these mutations can help in the development of vaccines and treatments.
Article
Biology
Michael Barton et al.
Summary: The study analyzed the effects of mutations in the Spike protein of SARS-CoV-2 on its interaction with ACE2, finding that most mutations increased affinity with ACE2. Two ACE2 mutations were also found to enhance binding with the Spike protein.
Article
Microbiology
Jiri Zahradnik et al.
Summary: In vitro evolution of the SARS-CoV-2 spike protein receptor-binding domain successfully generated a high-affinity variant effective in inhibiting virus infection. Mutations present in more transmissible viruses were preferentially selected, and increased affinity to ACE2 was positively correlated with the incidence of RBD mutations in the population. The study also identified mutations with potential higher infectivity, and the high-affinity RBD variant showed efficacy in inhibiting infection in vitro and reducing clinical disease in a hamster model of SARS-CoV-2 challenge.
NATURE MICROBIOLOGY
(2021)
Letter
Medicine, General & Internal
Josh Torgovnick
NEW ENGLAND JOURNAL OF MEDICINE
(2021)
Article
Chemistry, Multidisciplinary
Jiahui Chen et al.
Summary: This study examines the impact of mutations on the spike protein of COVID-19, particularly on vaccines and antibody therapies. The research findings reveal that certain mutations may weaken the binding between the spike protein and antibodies, potentially reducing the efficacy of current treatments. Moreover, it is discovered that some mutations could enhance the binding between the spike protein and human angiotensin-converting enzyme 2 (ACE2), leading to more infectious variants of the virus.
Article
Immunology
Xiao-Ning Li et al.
Summary: The two-dose inactivated SARS-CoV-2 vaccine showed an effectiveness of 59.0% to 70.2% against the Delta variant, with higher efficacy among participants aged 40-59 years and in females compared to males in preventing COVID-19 and moderate diseases.
EMERGING MICROBES & INFECTIONS
(2021)
Article
Biochemistry & Molecular Biology
Markus Hoffmann et al.
Article
Infectious Diseases
Lucy van Dorp et al.
INFECTION GENETICS AND EVOLUTION
(2020)
Review
Immunology
Zeinab Abdelrahman et al.
FRONTIERS IN IMMUNOLOGY
(2020)
Review
Biochemistry & Molecular Biology
Fei Yu et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY
(2020)
Article
Biochemical Research Methods
Konstantin Okonechnikov et al.
